Cargando…

Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy

Antiangiogenic agents, such as ramucirumab, should be cautiously administered along with radiotherapy because of the enhanced risk of adverse events.

Detalles Bibliográficos
Autores principales: Akahane, Keiko, Shirai, Katsuyuki, Wakatsuki, Masaru, Ogawa, Kazunari, Minato, Kyosuke, Hamamoto, Kohei, Takahashi, Satoru, Suzuki, Koichi, Takahashi, Jun, Rikiyama, Toshiki, Matsumoto, Keita, Mashima, Hirosato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250969/
https://www.ncbi.nlm.nih.gov/pubmed/32477545
http://dx.doi.org/10.1002/ccr3.2751
_version_ 1783538865577918464
author Akahane, Keiko
Shirai, Katsuyuki
Wakatsuki, Masaru
Ogawa, Kazunari
Minato, Kyosuke
Hamamoto, Kohei
Takahashi, Satoru
Suzuki, Koichi
Takahashi, Jun
Rikiyama, Toshiki
Matsumoto, Keita
Mashima, Hirosato
author_facet Akahane, Keiko
Shirai, Katsuyuki
Wakatsuki, Masaru
Ogawa, Kazunari
Minato, Kyosuke
Hamamoto, Kohei
Takahashi, Satoru
Suzuki, Koichi
Takahashi, Jun
Rikiyama, Toshiki
Matsumoto, Keita
Mashima, Hirosato
author_sort Akahane, Keiko
collection PubMed
description Antiangiogenic agents, such as ramucirumab, should be cautiously administered along with radiotherapy because of the enhanced risk of adverse events.
format Online
Article
Text
id pubmed-7250969
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72509692020-05-29 Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy Akahane, Keiko Shirai, Katsuyuki Wakatsuki, Masaru Ogawa, Kazunari Minato, Kyosuke Hamamoto, Kohei Takahashi, Satoru Suzuki, Koichi Takahashi, Jun Rikiyama, Toshiki Matsumoto, Keita Mashima, Hirosato Clin Case Rep Case Reports Antiangiogenic agents, such as ramucirumab, should be cautiously administered along with radiotherapy because of the enhanced risk of adverse events. John Wiley and Sons Inc. 2020-03-09 /pmc/articles/PMC7250969/ /pubmed/32477545 http://dx.doi.org/10.1002/ccr3.2751 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Akahane, Keiko
Shirai, Katsuyuki
Wakatsuki, Masaru
Ogawa, Kazunari
Minato, Kyosuke
Hamamoto, Kohei
Takahashi, Satoru
Suzuki, Koichi
Takahashi, Jun
Rikiyama, Toshiki
Matsumoto, Keita
Mashima, Hirosato
Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy
title Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy
title_full Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy
title_fullStr Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy
title_full_unstemmed Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy
title_short Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy
title_sort severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250969/
https://www.ncbi.nlm.nih.gov/pubmed/32477545
http://dx.doi.org/10.1002/ccr3.2751
work_keys_str_mv AT akahanekeiko severeesophagealstenosisinapatientwithmetastaticcoloncancerfollowingpalliativeradiotherapyramucirumabandchemotherapy
AT shiraikatsuyuki severeesophagealstenosisinapatientwithmetastaticcoloncancerfollowingpalliativeradiotherapyramucirumabandchemotherapy
AT wakatsukimasaru severeesophagealstenosisinapatientwithmetastaticcoloncancerfollowingpalliativeradiotherapyramucirumabandchemotherapy
AT ogawakazunari severeesophagealstenosisinapatientwithmetastaticcoloncancerfollowingpalliativeradiotherapyramucirumabandchemotherapy
AT minatokyosuke severeesophagealstenosisinapatientwithmetastaticcoloncancerfollowingpalliativeradiotherapyramucirumabandchemotherapy
AT hamamotokohei severeesophagealstenosisinapatientwithmetastaticcoloncancerfollowingpalliativeradiotherapyramucirumabandchemotherapy
AT takahashisatoru severeesophagealstenosisinapatientwithmetastaticcoloncancerfollowingpalliativeradiotherapyramucirumabandchemotherapy
AT suzukikoichi severeesophagealstenosisinapatientwithmetastaticcoloncancerfollowingpalliativeradiotherapyramucirumabandchemotherapy
AT takahashijun severeesophagealstenosisinapatientwithmetastaticcoloncancerfollowingpalliativeradiotherapyramucirumabandchemotherapy
AT rikiyamatoshiki severeesophagealstenosisinapatientwithmetastaticcoloncancerfollowingpalliativeradiotherapyramucirumabandchemotherapy
AT matsumotokeita severeesophagealstenosisinapatientwithmetastaticcoloncancerfollowingpalliativeradiotherapyramucirumabandchemotherapy
AT mashimahirosato severeesophagealstenosisinapatientwithmetastaticcoloncancerfollowingpalliativeradiotherapyramucirumabandchemotherapy